Antitubercular Triazines: Optimization and Intrabacterial Metabolism

The triazine antitubercular JSF-2019 was of interest due to its in vitro efficacy and the nitro group shared with the clinically relevant delamanid and pretomanid. JSF-2019 undergoes activation requiring F(420)H(2) and one or more nitroreductases in addition to Ddn. An intrabacterial drug metabolism...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cell Chem Biol
Autores principales: Wang, Xin, Inoyama, Daigo, Russo, Riccardo, Li, Shao-Gang, Jadhav, Ravindra, Stratton, Thomas P., Mittal, Nisha, Bilotta, Joseph A., Singleton, Eric, Kim, Thomas, Paget, Steve D., Pottorf, Richard S., Ahn, Yong-Mo, Davila-Pagan, Alejandro, Kandasamy, Srinivasan, Grady, Courtney, Hussain, Seema, Soteropoulos, Patricia, Zimmerman, Matthew D., Ho, Hsin Pin, Park, Steven, Dartois, Véronique, Ekins, Sean, Connell, Nancy, Kumar, Pradeep, Freundlich, Joel S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7035970/
https://ncbi.nlm.nih.gov/pubmed/31711854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chembiol.2019.10.010
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares